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From specific aim 1. Identification of the role of p38 MAP kinase, JNK and MAP kinase 
phosphatase-1 (MKP-1) in oxidative stress induced necrotic cell death. 
 
Studies with synthetic PARP inhibitors 
1. Determining the effect of the PARP-1 on the activation of MAP kinase systems 
including ERK1/2, p38 MAP kinase and JNK, and on the cell death process. Our data 
show that inhibition of PARP-1 decrease the cell death in oxidative stress both necrotic 
and apoptotic processed as determined from propidium iodid and fluorescein labeled-
Annexin V labeling. PARP inhibition activates ERK1/2 determined by phosphorylation 
specific antibodies as described before, and decreases the activation JNK and p38 
MAP kinase. 
 
2. In oxidative stress, we provided evidence that PARP inhibition increase the oxidative 
stress dependent expression of MKP-1 which is the main phosphatase responsible for the 
inactivation of JNK and p38 MAP kinase, and so it can play a role in the PARP inhibition 
mediated mitochondrial protection.  
 
Studies with the transdominant expression of PARP-1 DNA-binding domain –which 
prevents PARP-1 activation- and by suppression of PARP-1 by siRNA.   
These techniques exclude the possibility that a synthetic molecule, beside PARP inhibition, might 
effects other signaling pathways.  
1. We provided evidence for the PARP inhibition/suppression induced suppression of JNK and 
p38 MAP kinases. 
2. We identified the overexpression of MKP-1/Dusp1 on the effect of PARP 
inhibition/suppression in oxidative stress. 
3. Providing evidence by suppression MKP-1/Dusp1 (with siRNA) on its critical role in the 
PARP inhibition regulatory effect on MAP kinases. 
 
In vivo studies. 
We provided evidence in several pathological systems, that the regulatory effects of 
PARP inhibition on kinases cascades are extremely important in cytoprotection.  
1. Identifying the importance of the PARP inhibition induced suppression of JNK and p38 MAP 
kinases in the protection against hypertensive cardiopathy. 
2. Providing evidence for the role of MAP kinase and PI-3-kinase-Akt pathways in the 
protection against neurodegenerative diseases. 
 
From specific aim 2.  Identification and proteomic analysis of the mitochondrial membrane 
proteins which are phosphorylated by Akt, and which can mediate the protective effect of Akt on 
mitochondria in oxidative stress. 
 
Using control mouse liver and liver from LPS induced secptic shock models we isolated 
mitochondria, and isolated proteins by anti-Akt substrates antibodies. That way we can isolates 
mitochondrial targets of Akt kinase, and comparing the data we can see which proteins are 
phosphorylated in septic shock. Since septic shock model animals mitochondrial permeability 
transition is taking place while in normal liver it is not, therefore these data may show 
which protein phosphorylation can contribute to mitochondrial permeability transition. 
 
Phosphoprotein analysis. 
We performed the analysis of Akt phosphorylated proteins by using antibody which 
recognizes the phosphorylated Akt sites. .  Using anti-Akt substrates antibodies we identified 
proteins by immunoprecitation followed by proteolysis and MS analysis. MS analysis 
were performed by nano-HPLC-Maxis (Brucker) system we identified GSK-3-beta 
phosphorylated on Ser-9 and phosphorylated cyclophilin D (site is unknown) as possible 
mitochondrial Akt targets. We found several other phosphoproteins with MS analysis but 
they did not were related to mitochondrial permeability transition.  In addition we 
identified them by Western blot with anti-p-GSK-3beta and anti-cyclophilin antibodies. 
The two independent techniques provided reliable data that Akt can regulate two 
important mitochondrial proteins which can play significant role in the regulation of 
mitochondrial permeability transition. 
Data from the literature indicated that cyclophilin D can undergo covalent modifications, 
which can be catalyzed by either extracellular signal regulated kinase (ERK) or glycogen 
synthase kinase (GSK-3beta) (A. Rasola, M. Sciacovelli, F. Chiara, B. Pantic, W.S. Brusilow, P. Bernardi, 
Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition, 
Proc. Natl Acad. Sci. USA 107 (2010) 726–731.). In addition it is suggested that recombinant GSK3 
could phosphorylate cyclophilin D and an in silico analysis identified possible GSK3 
target residues on [Rasola et al.]. It is known that Akt phosphorylates GSK-3beta at Ser-9, 
which inactivates the enzyme, and so protect against mitochondrial permeability 
transition. However, it is the first data showing that Akt can phosphorylate cyclophilin D 
and thereby can prevent cyclophilin D dependent mitochondrial permeability transition. 
 
From specific aim 3.  Providing evidence for the oxidative stress induced cytoplasmic (released 
from the nucleus) poly-ADP-ribose (PAR) and for PAR induced signal-transducting effects.  
The main question of this proposal was mechanism by which PARP activation/inhibition 
can regulate kinase cascades. First we thought that PAR polymer may get out to 
cytoplasm and can regulate directly mitochondria and kinases. Previously, it was 
suggested that the release of nuclearly formed ADP-ribose polymers or ADP-ribosylated 
proteins could be responsible for the cytosolic and mitochondrial effects of poly(ADP-
ribose) polymerase (PARP)-1 activation in oxidative stress. Dawsons group showed 
previously, that nuclear poly-ADP-ribose can get out to cytoplasm and can destabilize 
mitochondrial membrane system (Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-
induced cell death. Yu SW, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, Dawson VL. Proc Natl Acad Sci U 
S A. 2006 Nov 28;103(48):18314-9.). In our systems we can not get these data, and the suppressing 
of PARG which mediates increases in poly-ADP-ribose content has complex role in cell 
survival (Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 
cells. Erdélyi K, Bai P, Kovács I, Szabó E, Mocsár G, Kakuk A, Szabó C, Gergely P, Virág L. FASEB J. 2009 
Oct;23(10):3553-63. ). These and other data indicate that that Yu et al. data can be valid only 
their special cell systems. In other experimental systems several laboratories showed that 
inhibiting certain signaling pathways can prevent PARP activation induced cell death 
(Trends in Biochemical Sciences. Volume 31, Issue 6, June 2006, Pages 309–311Players in the PARP-1 cell-death 
pathway: JNK1 joins the cast. Conrad C. Alano, Raymond A. Swanson). Our previous data also showed 
that PARP activation mediated mitochondrial destabilization is a complex signaling 
processes (Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-
ribose)polymerase-1 inhibition in oxidative stress. Tapodi A, Debreceni B, Hanto K, Bognar Z, Wittmann I, Gallyas F 
Jr, Varbiro G, Sumegi B. J Biol Chem. 2005 Oct 21;280(42):35767-75.).  
Therefore the main question of this proposal was to discover the mechanism by which 
PARP activation/inhibition can regulate mitochondrial integrity and the activity of kinase 
cascades.  Our studies (Racz et al. Free Radic Biol Med. 2010 Dec 15;49(12):1978-88), we provide a 
novel alternative mechanism. We found that reactive oxygen species-activated PARP-1 
regulated the activation of JNK and p38 mitogen-activated protein kinases (MAPKs) 
because inhibition of PARP-1 by pharmacons, small interfering RNA silencing of PARP-
1 expression, or the transdominant expression of enzymatically inactive PARP-1 resulted 
in the inactivation of these MAPKs. This regulation was achieved by increased 
expression and enlarged cytoplasmic localization of MAPK phosphatase-1 (MKP-1) 
upon PARP-1 inhibition in oxidative stress because changes in MKP-1 expression were 
reflected in the phosphorylation states of JNK and p38. Furthermore, we found that in 
MKP-1-silenced cells, PARP inhibition was unable to exert its protective effect, 
indicating the pivotal roles of JNK and p38 in mediating the oxidative-stress-induced cell 
death as well as that of increased MKP-1 expression in mediating the protective effect of 
PARP inhibition. We suggest that regulation of a protein that can directly influence 
cytoplasmic signaling cascades at the expression level represents a novel mechanism for 
the cytoplasmic action of PARP-1 inhibition. 
Furthermore, we identified the mechanism by which PARP-1 directly modulated (poly-
ADP-ribosylates) nuclear transcription factors involved in the regulation of MKP-1, 2 & 
3 expression.  
 
From specific aim 4. Proteomic analysis of the cytoplasmic poly-ADP-ribose binding proteins. 
We isolated cytoplasmic protein in from hydrogene peroxide treated WRL68 cells and 
LPS treated mouse liver and subjected to either poly-ADP-ribose (PAR) affinity 
chromatography, or PAR immuno-precipitation by anti-PAR antibodies. By these 
methods we precipitated the cytoplasmic poly-ADP-ribose-binding proteins and 
cytoplasmic PARylated proteins. Proteins were separated by electrophoresis, or 2D 
electrophoresis, and identified by Brucker MALDI and MAXIS mass spectrometers.  
After several disappointing efforts we identified the following proteins binding to poly-
ADP-ribose, or PARylated proteins (see below). 
 
Q8BQD8 mouse Nucleolin, 
AAH09004, Protein phosphatase 1G, Mg-dep. 
Q8C1W9 nucleosome assembly protein 1-like 4, isoform. 
YBOX1 Mouse (Nuclease sensitive element-binding protein) 
BAA34736 likely Nucleosome assembly protein, 
and 4 other proteins with unknown function. 
 
After several unsuccessful experiment with these proteins we identified Creb2 as a 
PARylated protein in completely independent studies which regulated the expression of 
MKP-1(plus MKP-2, MKP-3), MAK kinase activation and cell death, therefore our 




From specific aim 5. Identification of those PAR-binding proteins which can regulate MAP 
kinases, or PI-3-kinase-Akt systems, and can play a role in necrotic cell death. 
 
Analysis of cytoplasmic effect of PARP inhibition take a new turn under our studies, as 
we discovered that the cytoplasmic effect of PARP inhibition on mitochondrial 
dependent cell death and MAP kinase regulation takes place by the activation of the 
expression and partially cytoplasmically localized MKP-1(and some other member of 
MKP family (manuscript under preparation)). Therefore, we focus on this new 
mechanism (Racz B, Hanto K, Tapodi A, Solti I, Kalman N, Jakus P, Kovacs K, Debreceni B, Gallyas F Jr, 
Sumegi B. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism 
for the cytoplasmic effect of PARP-1 activation. Free Radic Biol Med. 2010 Dec 15;49(12):1978-88), and we try 
to identify the PARP regulated transcription factor(s) which can be responsible for the 
regulation of certain members of MKP family.  
After two years of hard work we identified Creb2 as the transcription factor being 
responsible for PARP-1 mediated MKP expression in oxidative stress. We provided 
evidence that in oxidative stress PARP-1 poly-ADP-ribosylates and inactivates Creb2 
including the DNA binding of Creb2 (Racz et al. J. Biol. Chem submitted for publication). 
Therefore, PARP-1 activation in oxidative stress, by poly-ADP-ribosylation and 
inactivation of Creb2, decrease MKP-1 expression, and so activates JNK1 and p38MAPK 
which initiates mitochondrial permeability pore formation and cell death. That is, poly-
ADP-ribosylation is an important step in the regulation of cytoplasmic pathways, our data 
show that this retrograde communication is taking place by the regulation of MAP kinase 
phosphatases the main regulators of MAP kinases. 
 
We identified another PARylated protein which can be shuttled between nucleus and 
cytoplasm, and which can be responsible for PARP inhibition induced Akt activation. 
This protein was ATM kinase which is regulated and PARylated by PARP-1, and through 
PARylation PARP-1 can influence of its localization in cells (manuscript under 
preparation). It was showed before that ATM cytoplasmic export plays a key role in 
Akt1 activation (ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 
translocation by insulin in muscle cells. Halaby MJ, Hibma JC, He J, Yang DQ. Cell Signal. 2008 Aug;20(8):1555-
63.).  
 
That is, our efforts to identify poly-ADP-ribosylated proteins which can be involved in 
cell death, MAP kinase regulation and PI-3-K-Akt pathway regulation has been 
successfully accomplished after a lot of efforts. Our data showed that in these two 
retrograde pathways either ATM nuclear export, or the regulation of MKP-1 mRNA 
synthesis and export plays critical role, and nuclear PARylation are involved, and not the 
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